The CyberKnife System offers a non-surgical, non-invasive treatment option that delivers proven results for a wide range of cancers and metastases. CyberKnife provides stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS), closely related types of radiation therapy that involve delivering a relatively higher dose of radiation with extreme accuracy. The high level of precision of this approach — also called hypofractionation — enables a higher dose of radiation to be delivered to a tumor in significantly fewer treatment sessions, while also reducing the radiation exposure to surrounding healthy tissues.
By delivering a high dose of radiation directly to the tumor, CyberKnife treatment is proven to provide excellent long-term outcomes.
CyberKnife treatment is an outpatient procedure that requires no incisions, no general anesthesia, no hospitalization and no long recovery period.
CyberKnife treatment can be completed in dramatically fewer treatment sessions, compared to conventional radiation therapy.
The unparalleled, sub-millimeter precision of CyberKnife treatment significantly reduces the risk of common side effects.
For additional information on what to expect before, during and after your CyberKnife treatment, please choose your cancer type:
© 2024 Accuray Incorporated. All rights reserved.
Educating others about your experience with the CyberKnife® System can help others who face similar decisions about their own cancer treatment choices.
If you are interested in sharing your story, please fill out the form below and an Accuray representative will contact you.
